Drug
Desonide
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Macular Degeneration | 787 | 299.8 | 356.3 | signal |
| 2 | Vaginal Discharge | 153 | 65.5 | 67.6 | signal |
| 3 | Paraesthesia Oral | 200 | 59.8 | 62.3 | signal |
| 4 | Oral Candidiasis | 156 | 51.4 | 53.1 | signal |
| 5 | Procedural Pain | 183 | 28.2 | 29.3 | signal |
| 6 | Frequent Bowel Movements | 162 | 25.7 | 26.5 | signal |
| 7 | Dermatitis Atopic | 240 | 20.4 | 21.4 | signal |
| 8 | Colitis | 167 | 18.9 | 19.5 | signal |
| 9 | Rectal Haemorrhage | 173 | 17.1 | 17.6 | signal |
| 10 | Therapeutic Product Effect Incomplete | 264 | 15.9 | 16.7 | signal |
| 11 | Colitis Ulcerative | 166 | 15.8 | 16.3 | signal |
| 12 | Sleep Disorder Due To A General Medical Condition | 60 | 15.8 | 16.0 | signal |
| 13 | Haematochezia | 174 | 13.4 | 13.9 | signal |
| 14 | Infusion Related Reaction | 200 | 12.9 | 13.4 | signal |
| 15 | Skin Fissures | 50 | 11.2 | 11.4 | signal |
| 16 | Eczema | 129 | 10.9 | 11.2 | signal |
| 17 | Dermatitis | 52 | 10.7 | 10.8 | signal |
| 18 | Conjunctivitis | 45 | 10.4 | 10.5 | signal |
| 19 | Psoriasis | 284 | 9.2 | 9.7 | signal |
| 20 | Skin Haemorrhage | 30 | 8.8 | 8.9 | signal |
| 21 | Dyspepsia | 203 | 8.8 | 9.1 | signal |
| 22 | Eye Pruritus | 67 | 8.6 | 8.7 | signal |
| 23 | Skin Exfoliation | 163 | 8.3 | 8.6 | signal |
| 24 | Scab | 22 | 8.2 | 8.3 | signal |
| 25 | Madarosis | 21 | 7.6 | 7.6 | signal |
| 26 | Eye Discharge | 18 | 7.5 | 7.5 | signal |
| 27 | Skin Infection | 18 | 6.8 | 6.9 | signal |
| 28 | Erythema | 314 | 6.5 | 6.9 | signal |
| 29 | Dermatitis Contact | 17 | 6.4 | 6.4 | signal |
| 30 | Psoriatic Arthropathy | 60 | 6.3 | 6.4 | signal |
| 31 | Dry Skin | 182 | 5.9 | 6.1 | signal |
| 32 | Skin Disorder | 46 | 5.9 | 5.9 | signal |
| 33 | Ocular Hyperaemia | 64 | 5.8 | 5.9 | signal |
| 34 | Dry Eye | 65 | 5.7 | 5.8 | signal |
| 35 | Neuralgia | 31 | 5.4 | 5.4 | signal |
| 36 | Impaired Quality Of Life | 18 | 5.3 | 5.3 | signal |
| 37 | Skin Lesion | 34 | 5.3 | 5.3 | signal |
| 38 | Tenderness | 13 | 5.3 | 5.3 | signal |
| 39 | Seasonal Allergy | 17 | 5.1 | 5.1 | signal |
| 40 | Pharyngitis Streptococcal | 13 | 5.1 | 5.1 | signal |
| 41 | Chronic Kidney Disease | 92 | 5.1 | 5.2 | signal |
| 42 | Pain Of Skin | 31 | 4.9 | 4.9 | signal |
| 43 | Basal Cell Carcinoma | 17 | 4.6 | 4.6 | signal |
| 44 | Product Dose Omission In Error | 29 | 4.6 | 4.6 | signal |
| 45 | Folliculitis | 11 | 4.5 | 4.5 | signal |
| 46 | Scratch | 11 | 4.5 | 4.5 | signal |
| 47 | Squamous Cell Carcinoma | 10 | 4.5 | 4.5 | signal |
| 48 | Eye Inflammation | 10 | 4.5 | 4.5 | signal |
| 49 | Eye Swelling | 39 | 4.5 | 4.5 | signal |
| 50 | Anaemia | 197 | 4.4 | 4.5 | signal |
| 51 | Oral Herpes | 20 | 4.4 | 4.4 | signal |
| 52 | Rash Pruritic | 55 | 4.3 | 4.4 | signal |
| 53 | Discomfort | 61 | 4.3 | 4.3 | signal |
| 54 | Weight Decreased | 276 | 4.2 | 4.4 | signal |
| 55 | Tooth Infection | 13 | 4.2 | 4.2 | signal |
| 56 | Therapeutic Response Shortened | 31 | 4.1 | 4.1 | signal |
| 57 | Therapeutic Response Decreased | 58 | 4.1 | 4.1 | signal |
| 58 | Constipation | 207 | 4.1 | 4.2 | signal |
| 59 | Abdominal Pain | 222 | 4.0 | 4.2 | signal |
| 60 | Sleep Disorder | 66 | 4.0 | 4.0 | signal |
| 61 | Eye Irritation | 51 | 3.9 | 3.9 | signal |
| 62 | Application Site Pain | 20 | 3.9 | 3.9 | signal |
| 63 | Pruritus | 343 | 3.8 | 4.1 | signal |
| 64 | Drug Ineffective | 1,194 | 3.8 | 4.7 | signal |
| 65 | Eye Infection | 10 | 3.8 | 3.8 | signal |
| 66 | Pyrexia | 306 | 3.7 | 3.9 | signal |
| 67 | Rash Macular | 30 | 3.7 | 3.7 | signal |
| 68 | Incorrect Product Administration Duration | 17 | 3.6 | 3.6 | signal |
| 69 | Sleep Apnoea Syndrome | 16 | 3.5 | 3.6 | signal |
| 70 | Ligament Sprain | 8 | 3.4 | 3.4 | signal |
| 71 | Lymphadenopathy | 28 | 3.3 | 3.4 | signal |
| 72 | Economic Problem | 12 | 3.3 | 3.3 | signal |
| 73 | Rotator Cuff Syndrome | 10 | 3.3 | 3.3 | signal |
| 74 | Bacteraemia | 9 | 3.2 | 3.2 | signal |
| 75 | End Stage Renal Disease | 14 | 3.2 | 3.2 | signal |
| 76 | Immune System Disorder | 10 | 3.2 | 3.2 | signal |
| 77 | Upper Respiratory Tract Infection | 35 | 3.2 | 3.2 | signal |
| 78 | Rash Papular | 17 | 3.2 | 3.2 | signal |
| 79 | Rash | 328 | 3.2 | 3.4 | signal |
| 80 | Ear Infection | 20 | 3.2 | 3.2 | signal |
| 81 | Intervertebral Disc Degeneration | 7 | 3.2 | 3.2 | signal |
| 82 | Rash Erythematous | 35 | 3.2 | 3.2 | signal |
| 83 | Arteriosclerosis | 7 | 3.1 | 3.2 | signal |
| 84 | Lacrimation Increased | 22 | 3.1 | 3.1 | signal |
| 85 | Coronary Artery Occlusion | 10 | 3.1 | 3.1 | signal |
| 86 | Dermatitis Allergic | 9 | 3.1 | 3.1 | signal |
| 87 | Osteopenia | 11 | 3.1 | 3.1 | signal |
| 88 | Vitreous Floaters | 7 | 3.0 | 3.0 | signal |
| 89 | Nerve Injury | 8 | 3.0 | 3.0 | signal |
| 90 | Anhedonia | 19 | 3.0 | 3.0 | signal |
| 91 | Lymphoma | 11 | 3.0 | 3.0 | signal |
| 92 | Rebound Effect | 8 | 3.0 | 3.0 | signal |
| 93 | Treatment Failure | 57 | 2.9 | 3.0 | signal |
| 94 | Neoplasm | 8 | 2.9 | 2.9 | signal |
| 95 | Ventricular Tachycardia | 11 | 2.8 | 2.8 | signal |
| 96 | Skin Burning Sensation | 47 | 2.8 | 2.8 | signal |
| 97 | Skin Discolouration | 30 | 2.8 | 2.8 | signal |
| 98 | Retinal Detachment | 6 | 2.8 | 2.8 | signal |
| 99 | Cardiomegaly | 8 | 2.7 | 2.7 | signal |
| 100 | Malaise | 282 | 2.7 | 2.8 | signal |
| 101 | Intervertebral Disc Protrusion | 14 | 2.7 | 2.7 | signal |
| 102 | Pain | 391 | 2.7 | 2.8 | signal |
| 103 | Oral Pain | 14 | 2.6 | 2.6 | signal |
| 104 | Sinusitis | 64 | 2.6 | 2.7 | signal |
| 105 | Coronary Artery Disease | 19 | 2.6 | 2.6 | signal |
| 106 | Ear Pain | 12 | 2.6 | 2.6 | signal |
| 107 | Thirst | 11 | 2.6 | 2.6 | signal |
| 108 | Sinus Disorder | 12 | 2.6 | 2.6 | signal |
| 109 | Therapy Partial Responder | 9 | 2.5 | 2.5 | signal |
| 110 | Hip Arthroplasty | 9 | 2.5 | 2.5 | signal |
| 111 | Tooth Abscess | 6 | 2.5 | 2.5 | no signal |
| 112 | Injection Site Discomfort | 6 | 2.5 | 2.5 | no signal |
| 113 | Spinal Operation | 7 | 2.5 | 2.5 | signal |
| 114 | Cellulitis | 29 | 2.4 | 2.4 | signal |
| 115 | Staphylococcal Infection | 19 | 2.4 | 2.4 | signal |
| 116 | Burning Sensation | 40 | 2.4 | 2.4 | signal |
| 117 | Product Use In Unapproved Indication | 139 | 2.4 | 2.5 | signal |
| 118 | Drug Eruption | 10 | 2.4 | 2.4 | signal |
| 119 | Incontinence | 6 | 2.4 | 2.4 | no signal |
| 120 | Bronchitis | 42 | 2.4 | 2.4 | signal |
| 121 | Haemorrhoids | 11 | 2.4 | 2.4 | signal |
| 122 | Gout | 10 | 2.4 | 2.4 | signal |
| 123 | Body Height Decreased | 6 | 2.4 | 2.4 | no signal |
| 124 | Renal Failure | 74 | 2.3 | 2.4 | signal |
| 125 | Osteomyelitis | 10 | 2.3 | 2.3 | signal |
| 126 | Inflammation | 28 | 2.3 | 2.3 | signal |
| 127 | Eye Pain | 30 | 2.3 | 2.3 | signal |
| 128 | Appendicitis | 5 | 2.3 | 2.3 | no signal |
| 129 | Middle Insomnia | 10 | 2.3 | 2.3 | signal |
| 130 | Photophobia | 10 | 2.3 | 2.3 | signal |
| 131 | Tubulointerstitial Nephritis | 10 | 2.3 | 2.3 | signal |
| 132 | Nephropathy | 5 | 2.3 | 2.3 | no signal |
| 133 | Face Oedema | 9 | 2.3 | 2.3 | signal |
| 134 | Nasal Congestion | 31 | 2.2 | 2.3 | signal |
| 135 | Laceration | 5 | 2.2 | 2.2 | no signal |
| 136 | Malignant Melanoma | 7 | 2.2 | 2.2 | no signal |
| 137 | Metastases To Lung | 6 | 2.2 | 2.2 | no signal |
| 138 | Glaucoma | 10 | 2.2 | 2.2 | signal |
| 139 | Tendonitis | 8 | 2.2 | 2.2 | no signal |
| 140 | Decreased Immune Responsiveness | 5 | 2.2 | 2.2 | no signal |
| 141 | Viral Infection | 17 | 2.2 | 2.2 | signal |
| 142 | Headache | 320 | 2.2 | 2.2 | signal |
| 143 | Kidney Infection | 10 | 2.2 | 2.2 | signal |
| 144 | Blood Iron Decreased | 6 | 2.2 | 2.2 | no signal |
| 145 | Inflammatory Bowel Disease | 5 | 2.2 | 2.2 | no signal |
| 146 | Cyanosis | 8 | 2.2 | 2.2 | no signal |
| 147 | Application Site Rash | 7 | 2.1 | 2.2 | no signal |
| 148 | Product Prescribing Error | 12 | 2.1 | 2.2 | signal |
| 149 | Wrist Fracture | 6 | 2.1 | 2.1 | no signal |
| 150 | Pneumocystis Jirovecii Pneumonia | 5 | 2.1 | 2.1 | no signal |
| 151 | Urticaria | 83 | 2.1 | 2.1 | signal |
| 152 | Ovarian Cyst | 5 | 2.1 | 2.1 | no signal |
| 153 | Drug Effect Less Than Expected | 7 | 2.1 | 2.1 | no signal |
| 154 | Toxic Skin Eruption | 5 | 2.1 | 2.1 | no signal |
| 155 | Hypersomnia | 14 | 2.1 | 2.1 | signal |
| 156 | Emotional Distress | 59 | 2.1 | 2.1 | signal |
| 157 | Secretion Discharge | 6 | 2.1 | 2.1 | no signal |
| 158 | Off Label Use | 420 | 2.1 | 2.1 | signal |
| 159 | Febrile Neutropenia | 32 | 2.0 | 2.1 | signal |
| 160 | Pharyngitis | 6 | 2.0 | 2.0 | no signal |
| 161 | Limb Injury | 13 | 2.0 | 2.0 | signal |
| 162 | Pulmonary Hypertension | 10 | 2.0 | 2.0 | signal |
| 163 | Swelling Face | 31 | 2.0 | 2.0 | signal |
| 164 | Full Blood Count Abnormal | 5 | 2.0 | 2.0 | no signal |
| 165 | Arthritis | 37 | 2.0 | 2.0 | no signal |
| 166 | Irritable Bowel Syndrome | 10 | 2.0 | 2.0 | no signal |
| 167 | Renal Injury | 14 | 2.0 | 2.0 | no signal |
| 168 | Platelet Count Increased | 6 | 1.9 | 1.9 | no signal |
| 169 | Inappropriate Schedule Of Product Administration | 80 | 1.9 | 1.9 | no signal |
| 170 | Joint Range Of Motion Decreased | 6 | 1.9 | 1.9 | no signal |
| 171 | Alopecia | 88 | 1.9 | 1.9 | no signal |
| 172 | Stress | 32 | 1.9 | 1.9 | no signal |
| 173 | Hair Texture Abnormal | 6 | 1.9 | 1.9 | no signal |
| 174 | Uveitis | 6 | 1.9 | 1.9 | no signal |
| 175 | Fistula | 5 | 1.9 | 1.9 | no signal |
| 176 | Sinus Congestion | 6 | 1.9 | 1.9 | no signal |
| 177 | Toothache | 8 | 1.9 | 1.9 | no signal |
| 178 | Skin Irritation | 20 | 1.8 | 1.9 | no signal |
| 179 | Diverticulitis | 12 | 1.8 | 1.8 | no signal |
| 180 | Muscle Tightness | 7 | 1.8 | 1.8 | no signal |
| 181 | Tooth Loss | 9 | 1.8 | 1.8 | no signal |
| 182 | Back Disorder | 7 | 1.8 | 1.8 | no signal |
| 183 | Eye Disorder | 14 | 1.8 | 1.8 | no signal |
| 184 | Abortion Induced | 4 | 1.8 | 1.8 | no signal |
| 185 | Injection Site Reaction | 29 | 1.8 | 1.8 | no signal |
| 186 | Spinal Disorder | 4 | 1.8 | 1.8 | no signal |
| 187 | Oropharyngeal Pain | 39 | 1.8 | 1.8 | no signal |
| 188 | Injection Site Pruritus | 28 | 1.8 | 1.8 | no signal |
| 189 | Influenza | 47 | 1.8 | 1.8 | no signal |
| 190 | Skin Cancer | 9 | 1.8 | 1.8 | no signal |
| 191 | Localised Infection | 10 | 1.8 | 1.8 | no signal |
| 192 | Bone Density Decreased | 13 | 1.7 | 1.7 | no signal |
| 193 | Illness | 41 | 1.7 | 1.7 | no signal |
| 194 | Angioedema | 18 | 1.7 | 1.7 | no signal |
| 195 | Insurance Issue | 6 | 1.7 | 1.7 | no signal |
| 196 | Tooth Extraction | 5 | 1.7 | 1.7 | no signal |
| 197 | Osteonecrosis Of Jaw | 10 | 1.7 | 1.7 | no signal |
| 198 | Migraine | 38 | 1.7 | 1.7 | no signal |
| 199 | Upper Limb Fracture | 8 | 1.7 | 1.7 | no signal |
| 200 | Herpes Zoster | 23 | 1.7 | 1.7 | no signal |
| 201 | Exposure Via Skin Contact | 9 | 1.7 | 1.7 | no signal |
| 202 | Hair Colour Changes | 5 | 1.7 | 1.7 | no signal |
| 203 | Application Site Pruritus | 9 | 1.7 | 1.7 | no signal |
| 204 | Injection Site Rash | 12 | 1.7 | 1.7 | no signal |
| 205 | Bone Loss | 6 | 1.7 | 1.7 | no signal |
| 206 | Initial Insomnia | 4 | 1.7 | 1.7 | no signal |
| 207 | Osteonecrosis | 13 | 1.7 | 1.7 | no signal |
| 208 | Drug Level Decreased | 4 | 1.7 | 1.7 | no signal |
| 209 | Ear Discomfort | 4 | 1.7 | 1.7 | no signal |
| 210 | Product Dose Omission Issue | 111 | 1.7 | 1.7 | no signal |
| 211 | Injection Site Warmth | 8 | 1.6 | 1.6 | no signal |
| 212 | Nodule | 5 | 1.6 | 1.6 | no signal |
| 213 | Bedridden | 5 | 1.6 | 1.6 | no signal |
| 214 | Surgery | 22 | 1.6 | 1.6 | no signal |
| 215 | Injection Site Pain | 114 | 1.6 | 1.6 | no signal |
| 216 | Injection Site Urticaria | 9 | 1.6 | 1.6 | no signal |
| 217 | Injection Site Swelling | 28 | 1.6 | 1.6 | no signal |
| 218 | Ocular Discomfort | 4 | 1.6 | 1.6 | no signal |
| 219 | Pruritus Generalised | 8 | 1.5 | 1.5 | no signal |
| 220 | Skin Reaction | 5 | 1.5 | 1.5 | no signal |
| 221 | Impaired Driving Ability | 4 | 1.5 | 1.5 | no signal |
| 222 | Mental Disorder | 15 | 1.5 | 1.5 | no signal |
| 223 | Arthropathy | 19 | 1.4 | 1.4 | no signal |
| 224 | Product Preparation Error | 7 | 1.4 | 1.4 | no signal |
| 225 | Withdrawal Syndrome | 14 | 1.4 | 1.4 | no signal |
| 226 | Expired Product Administered | 11 | 1.4 | 1.4 | no signal |
| 227 | Unevaluable Event | 25 | 1.4 | 1.4 | no signal |
| 228 | Blood Count Abnormal | 5 | 1.4 | 1.4 | no signal |
| 229 | Tendon Rupture | 4 | 1.4 | 1.4 | no signal |
| 230 | Emotional Disorder | 10 | 1.4 | 1.4 | no signal |
| 231 | Application Site Irritation | 4 | 1.4 | 1.4 | no signal |
| 232 | Injection Site Irritation | 4 | 1.3 | 1.3 | no signal |
| 233 | Therapeutic Product Effect Decreased | 14 | 1.3 | 1.3 | no signal |
| 234 | Affect Lability | 3 | 1.3 | 1.3 | no signal |
| 235 | Injection Site Induration | 4 | 1.3 | 1.3 | no signal |
| 236 | Application Site Erythema | 8 | 1.3 | 1.3 | no signal |
| 237 | Product Physical Issue | 6 | 1.3 | 1.3 | no signal |
| 238 | Activities Of Daily Living Impaired | 6 | 1.3 | 1.3 | no signal |
| 239 | Injection Site Mass | 11 | 1.3 | 1.3 | no signal |
| 240 | Product Prescribing Issue | 6 | 1.2 | 1.2 | no signal |
| 241 | Incorrect Dose Administered | 66 | 1.2 | 1.2 | no signal |
| 242 | Product Dose Omission | 19 | 1.2 | 1.2 | no signal |
| 243 | Eosinophilia | 5 | 1.2 | 1.2 | no signal |
| 244 | Systemic Lupus Erythematosus | 10 | 1.2 | 1.2 | no signal |
| 245 | Acne | 21 | 1.2 | 1.2 | no signal |
| 246 | Colon Cancer | 4 | 1.1 | 1.1 | no signal |
| 247 | Injection Site Bruising | 21 | 1.1 | 1.1 | no signal |
| 248 | Maternal Exposure During Pregnancy | 23 | 1.1 | 1.1 | no signal |
| 249 | Injection Site Erythema | 32 | 1.1 | 1.1 | no signal |
| 250 | Cytopenia | 3 | 1.1 | 1.1 | no signal |
| 251 | Pregnancy | 5 | 1.0 | 1.0 | no signal |
| 252 | Hepatic Cytolysis | 3 | 1.0 | 1.0 | no signal |
| 253 | Mania | 4 | 1.0 | 1.0 | no signal |
| 254 | Libido Decreased | 3 | 1.0 | 1.0 | no signal |
| 255 | Injection Site Discolouration | 3 | 1.0 | 1.0 | no signal |
| 256 | Pemphigus | 3 | 1.0 | 1.0 | no signal |
| 257 | Neoplasm Malignant | 16 | 1.0 | 1.0 | no signal |
| 258 | Anger | 8 | 1.0 | 1.0 | no signal |
| 259 | Intraocular Pressure Increased | 3 | 1.0 | 1.0 | no signal |
| 260 | Ankylosing Spondylitis | 3 | 1.0 | 1.0 | no signal |
| 261 | Product Dispensing Error | 5 | 1.0 | 1.0 | no signal |
| 262 | Syringe Issue | 4 | 1.0 | 1.0 | no signal |
| 263 | Extra Dose Administered | 9 | 1.0 | 1.0 | no signal |
| 264 | Synovitis | 4 | 0.9 | 0.9 | no signal |
| 265 | Drug Effect Incomplete | 8 | 0.9 | 0.9 | no signal |
| 266 | Incorrect Drug Administration Duration | 6 | 0.9 | 0.9 | no signal |
| 267 | Accidental Exposure To Product | 21 | 0.9 | 0.9 | no signal |
| 268 | Drug Effect Decreased | 11 | 0.9 | 0.9 | no signal |
| 269 | Glycosylated Haemoglobin Increased | 5 | 0.8 | 0.8 | no signal |
| 270 | Drug Dose Omission | 33 | 0.8 | 0.8 | no signal |
| 271 | Vaginal Haemorrhage | 8 | 0.8 | 0.8 | no signal |
| 272 | Multiple Fractures | 3 | 0.8 | 0.8 | no signal |
| 273 | Plasma Cell Myeloma | 7 | 0.8 | 0.8 | no signal |
| 274 | Injection Site Haemorrhage | 14 | 0.7 | 0.7 | no signal |
| 275 | Drug Effective For Unapproved Indication | 5 | 0.7 | 0.7 | no signal |
| 276 | Multiple Sclerosis | 8 | 0.7 | 0.7 | no signal |
| 277 | Incorrect Dose Administered By Device | 4 | 0.7 | 0.7 | no signal |
| 278 | Drug Prescribing Error | 3 | 0.7 | 0.7 | no signal |
| 279 | Menorrhagia | 3 | 0.6 | 0.6 | no signal |
| 280 | Abortion Spontaneous | 6 | 0.6 | 0.6 | no signal |
| 281 | Pancreatic Carcinoma | 4 | 0.6 | 0.6 | no signal |
| 282 | Breast Cancer | 11 | 0.5 | 0.5 | no signal |
| 283 | Device Issue | 10 | 0.5 | 0.5 | no signal |
| 284 | Menstruation Irregular | 3 | 0.5 | 0.5 | no signal |
| 285 | Drug Withdrawal Syndrome | 10 | 0.5 | 0.5 | no signal |
| 286 | Incorrect Route Of Drug Administration | 4 | 0.5 | 0.5 | no signal |
| 287 | Drug Exposure During Pregnancy | 3 | 0.4 | 0.4 | no signal |
| 288 | Drug Dependence | 14 | 0.4 | 0.4 | no signal |
| 289 | Bladder Cancer | 3 | 0.2 | 0.2 | no signal |